UCSF School of Pharmacy leads in NIH funding for 35th year in a row
For the 35th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.
School researchers were awarded $31.8 million during the 2014 fiscal year, from October 1, 2013 to September 30, 2014.
“The decades-long success of the School of Pharmacy in receiving this competitive funding is based on a faculty driven toward scientific discovery from the molecule to the bedside,” said Dean B. Joseph Guglielmo, PharmD. “The ultimate result of their work is evidenced by the improved health of patients through the development and use of more precise therapeutics.”
This year also marks the fifth year in a row in which a junior School faculty member has received the NIH Director’s New Innovator Award, which supports “exceptionally creative” early career researchers. This year’s awardee was Adam Abate, PhD, who is developing a method to swiftly sort and analyze the cells involved in autoimmune diseases like lupus and rheumatoid arthritis in order to develop better, more targeted treatments.
The top five School recipients of NIH funding in fiscal year 2014:
- Kathy Giacomini, PhD, $4,048,105
- Esteban Burchard, MD, MPH, $3,808,140
- Ruth Greenblatt, MD, $3,164,375
- Adam Abate, PhD, $2,916,913
- Al Burlingame, PhD, $1,746,341
About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.